MetaCap

Akebia Therapeutics Insider Trades

NASDAQ: AKBAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.8011-0.0137 (-1.68%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

After hours: 0.8075 +0.80%

Last 12 months

Purchases
1 · $86.59K
Sales
16 · $962.96K
Shares bought / sold
69.27K / 704.06K
Net activity
Net selling $876,368

Akebia Therapeutics insider activity

Over the last 12 months, Akebia Therapeutics insiders reported 31 transactions on SEC Form 4: 1 open-market purchase and 16 sales. Insiders bought $86,588 and sold $962,955 worth of stock, for net insider selling of $876,368. The largest seller was Butler John P., with $474,414 in reported sales.

The most recent filing shows Butler John P. (CEO and President) reporting a transaction in 350,000 shares at $0.63 on Aug 6, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put AKBA's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

AKBA insider transactions

Akebia Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Aug 6, 2026Butler John P.CEO and PresidentOption exercise350,000$220.50KForm 4
Jun 29, 2026Ostrowski ErikSVP, CFO, CBO & TreasurerSale56,019$62.18KForm 4
Jun 17, 2026ADAMS ADRIANDirectorAward35,700—Form 4
Jun 17, 2026ZUMWALT LEANNE MDirectorAward35,700—Form 4
Jun 17, 2026ROGERS MICHAEL WDirectorAward35,700—Form 4
Jun 17, 2026Smith CynthiaDirectorAward35,700—Form 4
Jun 17, 2026Wolf MylesDirectorAward35,700—Form 4
Jun 17, 2026FRIESON RONDirectorAward35,700—Form 4
Mar 4, 2026Butler John P.CEO and PresidentBuy69,270$86.59KForm 4
Feb 2, 2026Grund NicholasChief Commercial OfficerSale31,244$43.43KForm 4
Feb 2, 2026Grund NicholasChief Commercial OfficerSale53,585$74.48KForm 4
Feb 2, 2026Malabre Richard CSVP, Chief Accounting OfficerSale13,382$18.60KForm 4
Feb 2, 2026Malabre Richard CSVP, Chief Accounting OfficerSale36,142$50.24KForm 4
Feb 2, 2026Butler John P.CEO and PresidentSale83,689$116.33KForm 4
Feb 2, 2026Butler John P.CEO and PresidentAward175,250$247.10KForm 4
Feb 2, 2026Butler John P.CEO and PresidentSale114,891$159.70KForm 4
Feb 2, 2026Butler John P.CEO and PresidentSale96,065$133.53KForm 4
Feb 2, 2026Butler John P.CEO and PresidentSale46,660$64.86KForm 4
Feb 2, 2026Ostrowski ErikSVP, CFO, CBO & TreasurerSale34,951$48.58KForm 4
Feb 2, 2026Rucci Carolyn M.SVP, Chief Legal OfficerSale27,544$38.29KForm 4
Feb 2, 2026Rucci Carolyn M.SVP, Chief Legal OfficerSale25,382$35.28KForm 4
Feb 2, 2026Rucci Carolyn M.SVP, Chief Legal OfficerSale16,846$23.42KForm 4
Feb 2, 2026Burke Steven KeithSVP, Chief Medical OfficerSale20,701$28.77KForm 4
Feb 2, 2026Burke Steven KeithSVP, Chief Medical OfficerSale25,375$35.27KForm 4
Feb 2, 2026Burke Steven KeithSVP, Chief Medical OfficerSale21,582$30.00KForm 4
Jan 30, 2026Butler John P.CEO and PresidentAward743,000—Form 4
Jan 30, 2026Grund NicholasChief Commercial OfficerAward204,000—Form 4
Jan 30, 2026Ostrowski ErikSVP, CFO, CBO & TreasurerAward204,000—Form 4
Jan 30, 2026Malabre Richard CSVP, Chief Accounting OfficerAward79,000—Form 4
Jan 30, 2026Rucci Carolyn M.SVP, Chief Legal OfficerAward190,000—Form 4
Jan 30, 2026Burke Steven KeithSVP, Chief Medical OfficerAward204,000—Form 4
Jun 30, 2025Ostrowski ErikSVP, CFO, CBO & TreasurerSale41,314$151.62KForm 4
Jun 10, 2025FRIESON RONDirectorAward35,700—Form 4
Jun 10, 2025Smith CynthiaDirectorAward35,700—Form 4
Jun 10, 2025GILMAN STEVEN CDirectorAward35,700—Form 4
Jun 10, 2025ROGERS MICHAEL WDirectorAward35,700—Form 4
Jun 10, 2025Wolf MylesDirectorAward35,700—Form 4
Jun 10, 2025ADAMS ADRIANDirectorAward35,700—Form 4
Jun 10, 2025ZUMWALT LEANNE MDirectorAward35,700—Form 4
Jun 9, 2025Malabre Richard CSVP, Chief Accounting OfficerSale15,000$60.15KForm 4
Jun 9, 2025Malabre Richard CSVP, Chief Accounting OfficerOption exercise15,000$25.20KForm 4
Jun 4, 2025Malabre Richard CSVP, Chief Accounting OfficerSale13,334$47.07KForm 4
Mar 3, 2025Burke Steven KeithSVP, Chief Medical OfficerSale7,144$13.07KForm 4
Mar 3, 2025Butler John P.CEO and PresidentSale46,409$84.93KForm 4
Feb 3, 2025Grund NicholasChief Commercial OfficerSale55,621$116.80KForm 4
Feb 3, 2025Malabre Richard CSVP, Chief Accounting OfficerSale30,202$63.42KForm 4
Feb 3, 2025Burke Steven KeithSVP, Chief Medical OfficerSale27,236$57.20KForm 4
Feb 3, 2025Burke Steven KeithSVP, Chief Medical OfficerSale23,270$48.87KForm 4
Feb 3, 2025Butler John P.CEO and PresidentSale97,982$205.76KForm 4
Feb 3, 2025Butler John P.CEO and PresidentSale46,268$97.16KForm 4
Jan 31, 2025Ostrowski ErikSVP, CFO, CBO & TreasurerAward194,900—Form 4
Jan 31, 2025Grund NicholasChief Commercial OfficerAward194,900—Form 4
Jan 31, 2025Malabre Richard CSVP, Chief Accounting OfficerAward85,000—Form 4
Jan 31, 2025Burke Steven KeithSVP, Chief Medical OfficerAward194,900—Form 4
Jan 31, 2025Butler John P.CEO and PresidentAward701,000—Form 4
Jan 17, 2025FRIESON RONDirectorOption exercise20,100$9.04KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related